title: High-dose inhaled fluticasone and delayed hypersensitivity skin testing.
abstract: BACKGROUND
  Systemic steroids have been associated with anergy. Treatment with high-dose inhaled steroids has many documented systemic side effects, including adrenal suppression, reduction in growth velocity, and increased bone metabolism; however, little is known about their effect on delayed-type hypersensitivity (DTH).
  
  
  OBJECTIVE
  The purpose of this study was to determine if a 28-day course of high-dose inhaled fluticasone suppresses DTH to a standard panel of antigens.
  
  
  METHODS
  Forty-five healthy, steroid-naïve subjects volunteered for this randomized, double-blinded, placebo-controlled trial. All subjects had baseline DTH assessed by intradermal skin testing to a standard panel of antigens (tetanus, candida, mumps, and tuberculin) read 72 h after placement. Subjects were then randomized to receive placebo or high-dose inhaled fluticasone (880 micro g/d) for 28 days, after which a second DTH panel was performed. A third DTH panel was performed after a 30-day washout period.
  
  
  RESULTS
  Of the 45 enrolled subjects, 38 subjects completed the study, including 20 subjects in the placebo group and 18 subjects in the drug group. There was no significant difference in the amount of induration between drug and placebo groups for any of the three periods tested.
  
  
  CONCLUSIONS
  Twenty-eight days of treatment with high-dose inhaled fluticasone did not suppress DTH in healthy volunteers.
authors.affiliation: Wilford Hall Medical Center, Lackland AFB, San Antonio, TX, USA. Ronald.England@lackland.af.mil
authors.forename: Ronald W
authors.initials: RW
authors.lastname: England
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Nugent
authors.forename: Kurt W
authors.initials: KW
authors.lastname: Grathwohl
authors.forename: Larry
authors.initials: L
authors.lastname: Hagan
authors.forename: James M
authors.initials: JM
authors.lastname: Quinn
mesh_terms: D000280:Administration, Inhalation; D000328:Adult; D000730:Androstadienes / Q000008:administration & dosage*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D004311:Double-Blind Method; D005260:Female; D000068298:Fluticasone; D006801:Humans; D006968:Hypersensitivity, Delayed; D007109:Immunity / Q000187:drug effects*; D008297:Male; D011446:Prospective Studies; D012882:Skin Tests; D014374:Tuberculin Test
chemical_list: D000730:Androstadienes; D000893:Anti-Inflammatory Agents; D000068298:Fluticasone